市场调查报告书
商品编码
1119129
动物生物技术全球市场规模调查,按产品类型,按应用,按动物类型,按最终用途,按地区预测 2022-2028Global Animal Biotechnology Market Size study, segmented by Product Type by Application Animal Type by End-Use and Regional Forecasts 2022-2028 |
2021 年全球动物生物技术市场价值约为 226.6 亿美元,预计在 2022-2028 年的预测期内以超过 9.2% 的健康增长率增长。我来了。
动物生物技术是利用科学技术开发适用于製药、工业和农业应用的基因。各种动物疾病呈上升趋势,公共和私营公司对研究和开发活动的大量投资,以及政府促进动物健康的举措和运动。根据兽医癌症协会的数据,四分之一的狗最终会患上癌症,近 50% 的 10 岁以上的狗会患上癌症,”皮尤食品和生物技术倡议组织在 2018 年进行的一项研究。58% 的人反对涉及动物基因操作的科学研究。根据 2020 年 12 月发表在生物工程和生物技术前沿的一项题为“纳米疫苗在牛疾病预防中的应用”的研究,疫苗是预防和控制牛传染病的最有效策略之一。一。基于纳米粒子的疫苗平台(纳米疫苗)最近作为更传统疫苗平台的可行替代品而广受欢迎。因此,广泛使用疫苗预防和控制动物疾病有望推动市场增长。此外,由于人类消费食品的营养价值提高,更丰富、更便宜和更多样化的食品供应,保护农业用地,以及食品供应所需的动物减少,全球动物生物技术市场将在预测期内增长。它可能会增加市场增长。然而,转基因或克隆动物生产的食品对人类健康造成危害的可能性尚不清楚。
全球动物生物技术市场研究中考虑的关键区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。北美正面临越来越多的宠物饲养、人畜共患病和传染病等动物疾病的流行、动物健康支出的增加、兽医数量的增加以及用于药物开发的兽医数量的增加。有大量的医院和由于大量的动物生物技术研究和开发活动,主导全球动物生物技术市场的诊所。凭藉大量畜产品,亚太地区也是增长最快的市场,动物福利意识的增强和政府举措有望推动市场增长。
本报告中包括的主要市场参与者是:
拜耳
生物成因
勃林格殷格翰有限公司
Ivaoes 有限责任公司
默克公司
辉瑞公司
赛诺菲
圣克鲁斯生物技术
比尔巴克
硕腾公司
本研究的目的是确定近年来各个细分市场和国家/地区的市场规模,并预测未来 8 年的价值。该报告旨在捕捉所研究的每个地区和国家的行业的定性和定量方面。此外,它还提供了有关关键方面的详细信息,例如定义市场未来增长的驱动因素和挑战。此外,报告还应详细分析主要参与者的竞争格局和产品供应,以及微观市场中可供利益相关者投资的机会。市场的详细细分和子细分如下所述。
按产品类型。
诊断测试
疫苗
药品
生殖/遗传学
饲料添加剂
按应用程序
动物疾病诊断
动物疾病的治疗
动物预防医学
药物开发
按动物类型
伴侣
牲畜
按最终用户
实验室
护理点测试/内部测试
兽医诊所
杂项
按地区
北美
美国
加拿大
欧洲
英国
德国
法国
西班牙
意大利
其他欧洲
亚太地区
中国
印度
日本
澳大利亚
韩国
其他亚太地区
拉丁美洲
巴西
墨西哥
世界其他地方
此外,本研究考虑的年份是:
实际年份 - 2018 年、2019 年、2020 年
2021 年基准年
预测期 - 2022 年 至 2028 年
本报告的目标受众是全球动物生物技术市场。
主要咨询公司和顾问
大公司、中型公司、中小企业
风险投资
增值经销商 (VAR)
第三方知识提供者
投资银行家
投资者
Global Animal Biotechnology Market is valued approximately USD 22.66 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.2 % over the forecast period 2022-2028. Animal Biotechnology is the use of Science and Technology for developing genetically which are appropriate for pharmaceutical, industrial or agricultural applications. Increment in various animal diseases, large investment in research and development activities from both public and private firms, an increasing number of initiatives and campaigns are implemented by the government to promote animal health. According to Veterinary Cancer Society, 1 in 4 dogs will suffer from cancer at some point, and almost 50% of dogs over age 10 will develop cancer, According to a survey conducted by the Pew Initiative on Food and Biotechnology in 2018, 58 percent people opposed scientific research on the genetic engineering of animals. According to the study published in Frontiers in Bio-engineering and Biotechnology, titled 'Applications of Nanovaccines for Disease Prevention in Cattle' in December 2020, vaccines are one of the most effective strategies for preventing and controlling infectious illnesses in cattle. Nanoparticle-based vaccine platforms (nano vaccines) have recently gained traction as viable alternatives to more traditional vaccine platforms. The wide use of vaccines to prevent and control animal diseases is therefore expected to drive market growth. Also, enhanced nutritional content of food for human consumption, a more abundant, cheaper and varied food supply, agricultural land-use savings, a decrease in the number of animals needed for the food supply, the global Animal Biotechnology market is likely to increase the market growth during the forecast period. However, the unknown potential health effects to humans from food products created by transgenic or cloned animals
The key regions considered for the global Animal Biotechnology Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America dominates the global animal biotechnology market due to rising pet adoption rates, increasing prevalence of animal diseases such as zoonotic and infectious, increasing expenditure on animal health, growing pool of veterinarians, large number of research and development activities for pharmaceutical development large number of hospitals and clinics. Also, Asia Pacific is the fastest growing market due to large livestock animal pool, increasing awareness of animal welfare and introduction of government initiatives are expected to contribute positively to the market's growth.
Major market player included in this report are:
Bayer AG
Biogenesis Bago
Boehringer Ingelheim GmbH
Ivaoes, LLC
Merck and Co. Inc
Pfizer Inc
Sanofi
Santa Cruz Biotechnology, Inc.
Virbac
Zoetis Inc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Diagnostics Tests
Vaccines
Drugs
Reproductive and Genetic
Feed Additives
By Application:
Diagnosis of Animal Diseases
Treatment of Animal Diseases
Preventive Care of Animals
Drug Development
By Animal Type:
Companion
Livestock
By End-Use:
Laboratories
Point-of-Care Testing/In-house Testing
Veterinary Hospitals & Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the global Animal Biotechnology Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
List of figures